VIEWPOINT MOLECULAR TARGETING
"Next Generation Personalized Cancer Therapy"
Chief Science Officer: Michael Schultz
University: University of Iowa
Startup Officer: Paul Dymerski
Technology Area:
Website: http://www.viewpointmt.com
University: University of Iowa
Startup Officer: Paul Dymerski
Technology Area:
- Pharmaceuticals and Medical
Website: http://www.viewpointmt.com
Viewpoint Molecular Targeting, LLC is a pharmaceutical company that develops targeted radiation therapies and diagnostics for cancer, with a current focus on metastatic melanoma.
Articles to be posted soon.